ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $113 | -98.9% | 21 | -99.3% | 0.00% | – |
Q2 2023 | $9,926 | +141700.0% | 3,223 | +106.7% | 0.00% | – |
Q1 2023 | $7 | -22.2% | 1,559 | -16.1% | 0.00% | – |
Q4 2022 | $9 | -99.9% | 1,858 | -29.8% | 0.00% | – |
Q3 2022 | $17,000 | +750.0% | 2,648 | +389.5% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 541 | +77.4% | 0.00% | – |
Q1 2022 | $2,000 | -60.0% | 305 | -61.2% | 0.00% | – |
Q4 2021 | $5,000 | – | 786 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 401,200 | $2,556,000 | 2.70% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 219,180 | $1,396,000 | 0.14% |
Perceptive Advisors | 781,615 | $4,978,000 | 0.10% |
Kepos Capital LP | 50,000 | $319,000 | 0.02% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 15,000 | $96,000 | 0.02% |
TWO SIGMA INVESTMENTS, LP | 33,372 | $213,000 | 0.00% |
TWO SIGMA ADVISERS, LP | 49,600 | $316,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 2,045 | $13,000 | 0.00% |
NORTHERN TRUST CORP | 13,906 | $89,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |